Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2024

MissionIRNewsBreaks – Diamond Lake Minerals Inc. (DLMI), BOXABL Partner to Make ‘Quite the Impact’ in Affordable Housing Market

Diamond Lake Minerals (OTC: DLMI), a forward-thinking multi-strategy operating company specializing in digital assets and SEC-registered security tokens, today announced the beginning of its long-term real estate vision and working relationship with Boxabl, Inc. (“BOXABL”), a revolutionary modular home building … Continue reading

Posted in Diamond Lake Minerals Inc. DLMI | Leave a comment

MissionIRNewsBreaks – Zoned Properties Inc. (ZDPY) Featured in Bell2Bell Podcast

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, was featured in the latest episode of the Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. … Continue reading

Posted in Zoned Properties Inc. ZDPY | Leave a comment

SuperCom Ltd. (NASDAQ: SPCB) Delivers Solutions for Responding to Stalking Threats on Global Basis

The advent of the Internet, and increasingly smart computerized technology, has made the world an interconnected place, granting powerful informational tools to help people meet daily challenges. However, those same tools can also be used abusively by bad players, including … Continue reading

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Agreements to Add Charging Terminal Access for Users of Growing Da Ge App

FingerMotion (NASDAQ: FNGR), a mobile services and data company, through its contractually controlled entity, Shanghai JiuGe Information Technology Co. Ltd., is facilitating the expanded use of the Da Ge app. According to the announcement, the company is entering into arrangements … Continue reading

Posted in FingerMotion Inc. FNGR, Small Cap News | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of … Continue reading

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – SUIC Worldwide Holdings Ltd. (SUIC), I.Hart Group Ink Franchise Authorizations with MONGA Fried Chicken

SUIC Worldwide Holdings (OTC: SUIC), a publicly traded technology company, and its I.Hart Group Taiwan Ltd. have signed a franchise authorization with MONGA(C) Fried Chicken in Japan and in China’s Shandong Province. This is a key step as SUIC and I.Hart … Continue reading

Posted in SUIC Worldwide Holdings Ltd. SUIC | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio to 41; Maintains Focus on GLP-1 Clinical Studies for 2024

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, in the month of April 2024, added three new patents to its portfolio. This brings the total number of awarded patents globally to 41, a testament to the versatility … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company advancing its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization, recently appointed Amy Mahery to its board of directors. “A biotech commercialization leader, Ms. Mahery has built … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

SuperCom Ltd. (NASDAQ: SPCB) Confident in its EM Solutions’ Adoption Given Growing Reception and Demonstrated Advantages

SuperCom (NASDAQ: SPCB), a global leading provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments, is aware of the growing domestic violence cases and believes it has the technology to help … Continue reading

Posted in SuperCom Ltd. SPCB | Leave a comment